Yunus Guzel

7PUBLICATIONS
27CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Other psychology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 11, 2025
68 Ga-CXCR4-targeted PET/CT Outperforms 18 F-FDG PET/CT in FLT3-mutated AML M1 With Granulocytic Sarcoma : Theranostic Insights.

Özlem Beyler, Halil Kömek, Yunus Güzel

|Feb 20, 2025
Predictive value of the FIB-4 index, APRI, ALBI score, and GPR for overall survival in treatment-naïve metastatic colorectal cancer patients.

Mehmet Serdar Yıldırım, Yunus Güzel, Canan Can

|Nov 27, 2024
Superiority of 68 Ga-Trivehexin PET/CT Over 18 F-FDG PET/CT in the Evaluation of Lymph Nodes in Patients With Breast Cancer.

Halil Kömek, Yunus Güzel, İhsan Kaplan

|Mar 07, 2024
Local imaging to interpret tumor size in F18 fluorodeoxyglucose positron emission tomography/CT in lung cancers.

Şadiye Altun Tuzcu, İhsan Kaplan, İbrahim İbiloğlu

|Nov 10, 2023
The inferior performance of [<sup>68</sup>Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [<sup>177</sup>Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors.

Duygu Has Simsek, Yunus Guzel, Dilara Denizmen

|Dec 10, 2021
FAPI-04 Uptake in Healthy Tissues of Cancer Patients in <sup>68</sup>Ga-FAPI-04 PET/CT Imaging.

Cihan Gündoğan, Yunus Güzel, Canan Can

Pageof 2

Frequent Collaborators

4 joint publications

Halil Kömek

3 joint publications

Canan Can

3 joint publications

İhsan Kaplan

2 joint publications

Cihan Gundogan